1-6 of 6
Authors: Maria Gule
Journal Article
CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v84, https://doi.org/10.1093/neuonc/noad179.0324
Published: 10 November 2023
Journal Article
NCOG-23. ASSESSMENT OF NON-MEASURABLE DISEASE IN HIGH-GRADE GLIOMA: RANO-BASED 2D VS. 3D VOLUMETRICS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v218–v219, https://doi.org/10.1093/neuonc/noad179.0836
Published: 10 November 2023
Journal Article
IMG-15. PEDIATRIC GLIOBLASTOMAS CONTRAST ENHANCEMENT PATTERN IS PREDICTIVE OF SURVIVAL
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii358, https://doi.org/10.1093/neuonc/noaa222.350
Published: 04 December 2020
Journal Article
CTNI-02. TBCRC049: A PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF TUCATINIB, TRASTUZUMAB AND CAPECITABINE FOR THE TREATMENT OF LEPTOMENINGEAL METASTASIS IN HER2 POSITIVE BR1AST CANCER
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii41, https://doi.org/10.1093/neuonc/noaa215.169
Published: 09 November 2020
Journal Article
RARE-47. CHARACTERIZATION OF ADULT MEDULLOBLASTOMA; A RETROSPECTIVE REVIEW OF 200 PATIENTS AT MD ANDERSON CANCER CENTER
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi231–vi232, https://doi.org/10.1093/neuonc/noz175.1191
Published: 11 November 2019
Journal Article
RARE-13. CHARACTERIZATION OF ADULT MEDULLOBLASTOMA PATIENTS AT RECURRENCE: RETROSPECTIVE REVIEW OF THE MD ANDERSON CANCER CENTER EXPERIENCE
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi239, https://doi.org/10.1093/neuonc/noy148.989
Published: 05 November 2018
